S
Sterilis
Innovative medical waste company
About Sterilis
Sterilis Solutions, LLC is a privately held company that provides an on-site, on-demand solution for treating regulated medical waste (RMW). The company was founded in 2011, with the initial concept for its technology imagined in 2013 and developed over the subsequent five years. Headquartered in Chicago, Illinois, with operations and manufacturing in Boxborough and Springfield, Massachusetts, the company is led by CEO Andy Marshall.
The core of the company's offering is the patented Sterilis Solutions Remediator, a system that combines steam sterilization with a grinder to treat biohazardous materials. This process uses high-pressure steam to sterilize items like sharps containers, needles, syringes, and lab cultures, followed by grinding, which reduces the waste volume by as much as 80%. The resulting inert, confetti-like material can be disposed of in the regular municipal waste stream, offering a significant departure from the traditional haul-and-incinerate model. A full cycle takes approximately 60 minutes.
Sterilis Solutions targets a broad client base, including hospitals, surgical centers, clinics, laboratories, pharmacies, public safety departments, and airports. The business model centers on providing the Remediator system as a fixed-cost alternative to variable third-party hauling contracts, which are subject to annual price increases. This allows clients to manage costs, reduce liability, and improve environmental sustainability by eliminating the need for transportation and incineration of hazardous waste. The system features an integrated, cloud-based software that automatically logs compliance data and generates reports to meet state EPA standards, simplifying the administrative burden for clients.
In April 2024, Sterilis Solutions announced a strategic partnership with Polycarbin, a company focused on creating a circular economy for laboratory plastics. This collaboration enables customers to not only treat their medical waste on-site but also to have the resulting material enter a recycling stream, where it can be transformed into new laboratory products. This alliance enhances the company's value proposition by creating a closed-loop system for clients in the life sciences, pharmaceutical, and clinical diagnostics sectors.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Boxborough, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Wasson Enterprise
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sterilis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sterilis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.